Skip to content

A study of the effect of partial hydrolyzed formula supplemented with symbotics on the gut microbiota of young children with allergic history

A study of the effect of partial hydrolyzed formula supplemented with symbotics on the gut microbiota, temperament and sleep of young children with allergic histor

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046909
Enrollment
Unknown
Registered
2021-05-30
Start date
2019-12-18
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild gastointetinal discomforts

Interventions

Experimental group:feeding PHP formula supplement with symbotic
Control group:feeding ordinary formula

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 2 Years

Inclusion criteria

Inclusion criteria: 1. Aged 1-2 years; 2. Who has a history of mild milk protein allergy diagnosed by doctors and has recovered; 3. Accompanied by mild diarrhea, constipation, abdominal distension and / or sleep disorders; 4. The patient's Guardian sign the informed consent form to allow the researcher to cooperate with the whole process of clinical trial and collect clinical data and stool samples; 5. Children with normal growth and development agree to maintain the existing intervention program for the next three months.

Exclusion criteria

Exclusion criteria: 1. Children with severe multiple food allergy or intolerance; children with lactose intolerance; 2. There was a clear history of brain injury, cerebral palsy, encephalitis and other organic diseases; 3. The patients with other diseases were definitely diagnosed; 4. There are intestinal organic diseases, such as Hirschsprung's disease, intestinal obstruction, intussusception, etc; 5. Using antiallergic drugs and psychotropic drugs; 6. Probiotics, antibiotics, acid inhibitors and other drugs that affect the intestinal flora were used in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Questionnaires;

Countries

China

Contacts

Public ContactWang Yanxia

The Affiliated Hospital of Qingdao University

rosalee@126.com+86 532 82911223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026